XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Director [Member]
Preferred Stock [Member]
Director [Member]
Common Stock [Member]
Director [Member]
Additional Paid-in Capital [Member]
Director [Member]
Retained Earnings [Member]
Director [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2020           0 41,782      
Balance at Dec. 31, 2020           $ 0 $ 418 $ 147,963 $ (136,063) $ 12,318
Net loss                 (1,518) (1,518)
Stock-based compensation expense related to employee and director stock options               130   130
Stock-based compensation expense related to non-employee stock options               53   53
Balance (in shares) at Mar. 31, 2021             41,782      
Balance at Mar. 31, 2021             $ 418 148,146 (137,581) 10,983
Balance (in shares) at Dec. 31, 2020           0 41,782      
Balance at Dec. 31, 2020           $ 0 $ 418 147,963 (136,063) 12,318
Net loss                   (3,377)
Balance (in shares) at Jun. 30, 2021             44,615      
Balance at Jun. 30, 2021             $ 447 150,202 (139,440) 11,209
Balance (in shares) at Mar. 31, 2021             41,782      
Balance at Mar. 31, 2021             $ 418 148,146 (137,581) 10,983
Net loss                 (1,859) (1,859)
Stock-based compensation expense related to employee and director stock options               242   242
Vesting of director restricted stock awards (in shares)             160      
Vesting of director restricted stock awards             $ 2 (2)    
Stock-based compensation expense related to non-employee stock options               54   54
Issuance of warrants               13   13
Issuance of common stock, net of offering costs (in shares)             2,673      
Issuance of common stock, net of offering costs             $ 27 1,749   1,776
Balance (in shares) at Jun. 30, 2021             44,615      
Balance at Jun. 30, 2021             $ 447 150,202 (139,440) 11,209
Balance (in shares) at Dec. 31, 2021           14 47,766      
Balance at Dec. 31, 2021           $ 680 $ 478 150,900 (141,887) 10,171
Net loss           $ 0 $ 0 0 (111) (111)
Reclassification of Private Placement Warrants               7,502   7,502
Conversion of Series B Non-Voting Preferred Stock to common stock (in shares)           (1) (3,653)      
Conversion of Series B Non-Voting Preferred Stock to common stock           $ (71) $ (36) (35)    
Conversion of Series B Non-Voting Preferred Stock to common stock (in shares)           1 3,653      
Conversion of Series B Non-Voting Preferred Stock to common stock           $ 71 $ 36 35    
Stock-based compensation expense related to employee and director stock options               184   184
Conversion of Series B Non-Voting Preferred Stock to common stock           $ 71 $ 36 35    
Balance (in shares) at Mar. 31, 2022           13 51,419      
Balance at Mar. 31, 2022           $ 609 $ 514 158,621 (141,998) 17,746
Balance (in shares) at Dec. 31, 2021           14 47,766      
Balance at Dec. 31, 2021           $ 680 $ 478 150,900 (141,887) 10,171
Net loss                   (2,266)
Reclassification of Private Placement Warrants                   7,502
Conversion of Series B Non-Voting Preferred Stock to common stock                   (110)
Conversion of Series B Non-Voting Preferred Stock to common stock                   110
Conversion of Series B Non-Voting Preferred Stock to common stock                   110
Balance (in shares) at Jun. 30, 2022           12 53,513      
Balance at Jun. 30, 2022           $ 570 $ 535 158,793 (144,153) 15,745
Balance (in shares) at Mar. 31, 2022           13 51,419      
Balance at Mar. 31, 2022           $ 609 $ 514 158,621 (141,998) 17,746
Net loss                 (2,155) (2,155)
Conversion of Series B Non-Voting Preferred Stock to common stock (in shares)           1 (1,974)      
Conversion of Series B Non-Voting Preferred Stock to common stock           $ 39 $ (20) (19)   0
Conversion of Series B Non-Voting Preferred Stock to common stock (in shares)           (1) 1,974      
Conversion of Series B Non-Voting Preferred Stock to common stock           $ (39) $ 20 19   0
Stock-based compensation expense related to employee and director stock options           0 0 154 0 154
Conversion of Series B Non-Voting Preferred Stock to common stock           $ (39) $ 20 19   0
Vesting of director restricted stock awards (in shares) 0 120                
Vesting of director restricted stock awards $ 0 $ 1 $ (1) $ 0 $ 0          
Balance (in shares) at Jun. 30, 2022           12 53,513      
Balance at Jun. 30, 2022           $ 570 $ 535 $ 158,793 $ (144,153) $ 15,745